Acesion Pharma is a developer of medical drugs designed for the treatment of Atrial Fibrillation. The company's medical drugs develop treatments for Atrial Fibrillation, which is the most common type of cardiac arrhythmia, by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.